The Cooper Companies(COO) - 2025 Q3 - Earnings Call Presentation

Fiscal Year 2025 Guidance - CooperCompanies projects total revenue between $4,076 million and $4,096 million, representing organic growth of 4% to 4.5%[1] - CooperVision is expected to generate revenue between $2,734 million and $2,747 million, with organic growth of 4% to 5%[1] - CooperSurgical anticipates revenue between $1,343 million and $1,349 million, reflecting organic growth of 3% to 3.5%[1] - The company forecasts non-GAAP EPS to be in the range of $4.08 to $4.12[1] Q4 2025 Guidance - CooperCompanies estimates total revenue between $1,049 million and $1,069 million, indicating organic growth of 2% to 4%[1] - CooperVision's revenue is projected to be between $700 million and $713 million, with organic growth of 2% to 4%[1] - CooperSurgical expects revenue between $350 million and $356 million, showing organic growth of 2% to 4%[1] - The company predicts non-GAAP EPS to be between $1.10 and $1.14[1] Additional Information - Organic growth excludes the impact of acquisitions and discontinuations in the comparable period and is on a constant currency basis[2] - A reconciliation of non-GAAP measures to GAAP measures is available on the company's website[2] - The company has not provided reconciliation to GAAP for EPS guidance due to the difficulty in forecasting acquisition-related, integration, and restructuring charges and expenses[2]